missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human MATR3 (aa 145-233) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-57720 (PA5-57720. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a nuclear matrix protein, which is proposed to stabilize certain messenger RNA species. Mutations of this gene are associated with distal myopathy 2, which often includes vocal cord and pharyngeal weakness. Alternatively spliced transcript variants, including read-through transcripts composed of the upstream small nucleolar RNA host gene 4 (non-protein coding) and matrin 3 gene sequence, have been identified. Pseudogenes of this gene are located on chromosomes 1 and X.
Specifications
Specifications
| Accession Number | P43243 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 9782 |
| Name | Human MATR3 (aa 145-233) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1110061A14Rik; 2810017I02Rik; AI841759; ALS21; AW555618; D030046F20Rik; KIAA0723; MATR3; matrin 3; matrin-3; matrin-3-like protein; mKIAA0723; MPD2; nuclear scaffold protein P130/MAT3; P130/MAT3; VCPDM; vocal cord and pharyngeal weakness with distal myopathy |
| Common Name | MATR3 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction